HYGEIA Acquires Suzhou Yongding Hospital, CEC Capital Group Served as Exclusive Financial Advisor

HYGEIA (6078.HK) announced the acquisition of a 98% stake in Suzhou Yongding Hospital for a transaction size of RMB 1.7 billion. With this acquisition, Ascendent Capital, the controlling shareholder of Yongding Hospital, has completely divested its ownership in the hospital. After the closing of the acquisition, HYGEIA will fully integrate its subsidiary hospitals, with a focus on strengthening Yongding Hospital's oncology specialty to enhance the core value of the group. Additionally, leveraging Yongding Hospital's regional advantages, HYGEIA aims to strengthen its market position in the East China region and expand its nationwide hospital network.

CEC Capital Group served as the exclusive financial advisor for Suzhou Yongding Hospital in this transaction.

HYGEIA is dedicated to building a comprehensive medical service platform with a focus on oncology, targeting non-first-tier cities for oncology business development. Its service network covers 11 provinces and 18 cities across the country. The group continues to expand its business footprint through organic growth and strategic acquisitions. The acquisition of Suzhou Yongding Hospital represents an important strategic move for HYGEIA in the East China region, strengthening its development in this area.

Suzhou Yongding Hospital is a leading comprehensive hospital in the region, forming a medical alliance with medical institutions such as Suzhou University Affiliated First Hospital. It has established key departments such as hematology and oncology, and has cultivated a team of doctors and introduced leading experts to promote the coordinated development of internal medicine and surgery departments. In the future, HYGEIA plans to leverage Yongding Hospital's expertise in personnel, technology, and other aspects, in combination with its experienced management and operational team, to enhance academic support and synergistic empowerment for Yongding Hospital's multidisciplinary oncology business. This will optimize Yongding Hospital's revenue structure and further increase its revenue scale.